The existence of a living cell is completely determined by its metabolism – a set of a large number of interdependent chemical reactions proceeding routinely and consistently in time as well as in speed. The correct passage of these catalytic processes is possible only with the precise regulation of the work of enzyme proteins. As a result of metabolic reactions, a constant reproduction is carried out all structural and functional molecular components of the cell, determining its existence as a living system, i.e. the main the property of a living cell is its ability to reproduce itself. Cell metabolism includes hundreds of reactions and is a phenomenally complex self-regulating system.
The effective effect of Metabolic ETALON on complex patterns of cell biosynthesis was obtained by the method of selective separation of metabolic cascades passing through different intermediate stages and differing in the distribution of reaction rates at these stages, which made it possible to selectively influence pathological disorders of the catalysis of biochemical reactions, followed by the restoration of kinetic constants.For the first time in the drug ETALON (The Human Biochemical STANDARD), a sub-molecular method of eliminating imbalance was applied stationary metabolic flows, which always take place in cancer patients.
The active ingredients of ETALON are able to reactivate metabolic pathways previously weakened or disabled by various pathologies (especially cancer tumors and metastases), while allowing the removal of toxic catabolic products from the body of a cancer patient. The Etalon composition optimizes fatty acid oxidation, providing lipotropic and anti-necrotic effects. In cases of local fatty infiltration and accumulation of conjugated fats in the liver (or liver necrosis), the drug is incorporated and acts at the main stages of the intermediate metabolic process, and has a lipotropic effect on the liver. The content in the solution of precursors of co-enzymes and other necessary substrates required for certain enzyme reactions works to reduce the level of nitrogen in the blood, producing additional detoxification of the kidneys and liver.
The drug Metabolic ETALON, due to its pharmacokinetics, has a glucogenic and antiketogenic effect, normalizing the mitochondrial metabolism of cells subjected to hypoxia or ischemia under the influence of an abnormal cellular environment. Also, ETALON allows you to prevent a decrease in the intracellular content of ATP (adenosine triphosphoric acid), optimizing the energy-synthesizing functions of mitochondria under conditions of hypoxia. Moreover, the drug ensures the normal functioning of membrane ion channels, transmembrane migration of potassium and sodium ions, and maintenance of the reference cellular homeostasis. Metabolic ETALON shows a direct antihypoxic effect, increasing the tolerance of cells to a lack of oxygen even in the area of the tumor, as well as in relation to myocardial cells of the heart muscle in ischemic problems. The drug is highly effective in chorioretinal ischemia, as well as in decreased hearing acuity.
Actively reacting with peroxide radicals of proteins and lipids, has a modulating effect on most membrane-bound enzymes (phosphodiesterase, adenylate cyclase), ion channels, reduces the level of lipoprotein peroxide modification; blocks the synthesis of some prostaglandins, thromboxane and leukotrienes, improves the rheological properties of blood, inhibits platelet aggregation.
